Want to see HK:2135 full AI Analyst Report?
Raily Aesthetic Medicine International Holdings Limited (2135) AI Stock Analysis
Top Page
Raily Aesthetic Medicine International Holdings Limited
(HKEX:2135)
The score is primarily supported by improved 2025 financial performance (return to profitability and strong free cash flow), but is held back by fragile earnings quality and historical volatility. Technical indicators remain bearish (oversold RSI and negative MACD, with price below the 200-day average), while the low P/E provides a valuation offset.
Raily Aesthetic Medicine International Holdings Limited (2135) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 66.29M
- Dividend Yield
- ―
- Average Volume (3M)
- 78.37K
- Price to Earnings (P/E)
- 3.9
- Beta (1Y)
- 0.63
- Revenue Growth
- 36.68%
- EPS Growth
- ―
- Country
- Hong Kong
- Employees
- 264
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Raily Aesthetic Medicine International Holdings Limited Business Overview & Revenue Model
Company Description
Raily Aesthetic Medicine International Holdings Limited is an investment holding company primarily engaged in providing a comprehensive range of cosmetic medical services. Its operations are structured into three principal segments: Aesthetic Medical...
Raily Aesthetic Medicine International Holdings Limited Financial Statement Overview
Summary
Financials show a 2025 turnaround with improved margins, a return to small net profit, and much stronger operating/free cash flow. However, the net margin is still very thin and results have been volatile (multi-year losses and inconsistent cash generation), keeping the score only moderately positive.
Income Statement
44NeutralBalance Sheet
62PositiveCash Flow
53Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 217.97M | 184.51M | 199.34M | 189.38M | 164.52M | 188.37M |
| Gross Profit | 91.89M | 75.70M | 71.41M | 71.49M | 66.78M | 69.69M |
| EBITDA | 38.29M | 26.97M | -34.29M | -6.03M | 3.89M | -6.00M |
| Net Income | 13.39M | 1.82M | -59.21M | -32.46M | -15.91M | -17.69M |
Balance Sheet | ||||||
| Total Assets | 236.88M | 237.75M | 249.92M | 273.60M | 302.65M | 344.73M |
| Cash, Cash Equivalents and Short-Term Investments | 48.67M | 57.82M | 28.87M | 39.79M | 78.78M | 121.72M |
| Total Debt | 49.84M | 59.18M | 56.37M | 51.78M | 48.22M | 67.45M |
| Total Liabilities | 130.72M | 139.45M | 154.41M | 141.01M | 136.77M | 162.37M |
| Stockholders Equity | 112.18M | 107.88M | 104.13M | 138.12M | 166.08M | 178.22M |
Cash Flow | ||||||
| Free Cash Flow | 1.68M | 32.04M | -38.59M | -10.00M | -21.13M | -18.25M |
| Operating Cash Flow | 27.55M | 34.69M | 6.01M | 8.02M | -2.27M | -2.47M |
| Investing Cash Flow | -17.19M | 1.36M | -12.70M | -26.14M | 558.00K | -82.45M |
| Financing Cash Flow | 2.28M | -7.86M | 19.43M | -10.48M | -25.65M | 11.97M |
Raily Aesthetic Medicine International Holdings Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2135, the sentiment is Neutral. The current price of 0.11 is above the 20-day moving average (MA) of 0.11, below the 50-day MA of 0.11, and below the 200-day MA of 0.13, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 50.65 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:2135.
Raily Aesthetic Medicine International Holdings Limited Peers Comparison
Overall Rating
HK:237379Outperform- HK:213554Neutral
HK:663948Neutral
HK:388641Neutral
HK:830737Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:2373 | 79Outperform | HKD 4.17B | 8.81 | 31.63% | 4.33% | 22.71% | 43.58% |
| HK:2135 | 54Neutral | HKD 62.39M | 3.94 | 12.17% | ― | 36.68% | ― |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:6639 | 48Neutral | HKD 1.03B | 31.06 | 1.27% | ― | ― | ― |
| HK:3886 | 41Neutral | HKD 1.10B | 78.09 | 0.48% | 1.10% | -3.26% | ― |
| HK:8307 | 37Underperform | HKD 60.30M | 64.28 | 19.79% | ― | 6.13% | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:2135 | Raily Aesthetic Medicine International Holdings Limited | 0.11 | -0.00 | -3.45% | |
| HK:2373 | Beauty Farm Medical & Health Industry, Inc. | 16.62 | -12.33 | -42.60% | |
| HK:3886 | Town Health International Medical Group Ltd. | 0.16 | -0.11 | -40.07% | |
| HK:6639 | Arrail Group Ltd. | 1.83 | -0.09 | -4.74% | |
| HK:8307 | Medicskin Holdings Ltd. | 0.15 | -0.03 | -15.56% | |
| HK:2508 | Saint Bella Inc. | 2.30 | -3.70 | -61.67% |
Raily Aesthetic Medicine International Holdings Limited Corporate Events
Raily Aesthetic Medicine Cancels All Outstanding Share Options
Raily Aesthetic Medicine International Holdings Limited has cancelled all 47,276,437 outstanding share options previously granted under its share option scheme, effective 31 August 2026. The move follows a review by the board and remuneration committ...
Raily Aesthetic Medicine Swings to Profit on Strong First-Half Revenue Growth
Raily Aesthetic Medicine International Holdings Limited reported a sharp improvement in performance for the six months ended 30 June 2026, with revenue rising to RMB114.8 million from RMB84.6 million a year earlier. The group swung to a profit of RMB...
Raily Aesthetic Medicine Sets Board Meeting to Review Interim Results and Dividend
Raily Aesthetic Medicine International Holdings Limited has scheduled a board meeting for 28 August 2026 to review and approve the group’s unaudited interim results for the six months ended 30 June 2026. The board will also consider whether to...
Raily Aesthetic Medicine Signals Interim Profit on Strong Aesthetic Services and Equipment Sales
Raily Aesthetic Medicine International Holdings Limited, a Hong Kong-listed provider of aesthetic medical services and equipment, operates in the fast-growing medical beauty sector in China. The group generates revenue from both clinical aesthetic pr...
Raily Aesthetic Medicine Shifts Hong Kong Principal Office to Tsim Sha Tsui
Raily Aesthetic Medicine International Holdings Limited has announced a change to its principal place of business in Hong Kong, effective 7 August 2026. The company will relocate its main Hong Kong office from Tsuen Wan to Unit 02, 5/F, Kimberley Pla...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 29, 2026